Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.400
+0.400 (10.00%)
Sep 4, 2026, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $878.45 million as of September 8, 2026. Its market cap has increased by 271.22% in one year.
Market Cap
878.45M
Enterprise Value
806.51M
Revenue
615.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.40
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from 538.37M to 878.45M, an increase of 63.17%. That is a compound annual growth rate of 8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 878.45M | 205.89% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 289.36M |
| CytoDyn | 275.42M |
| Glorywin Entertainment Group | 234.77M |
| Vaxart | 120.20M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 80.25M |
| Sangamo Therapeutics | 66.70M |
| Nuo Therapeutics | 58.60M |